Ventas (Ventas) Risk Assessment

View and export this data going back to 1997. Start your Free Trial

What is Ventas Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Ventas is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of Ventas's Risk Assessment

For the REIT - Healthcare Facilities subindustry, Ventas's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ventas's Risk Assessment Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Ventas's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Ventas's Risk Assessment falls into.

Ventas (NYSE:VTR) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Ventas Risk Assessment Related Terms

Thank you for viewing the detailed overview of Ventas's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Ventas (Ventas) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Ventas Inc (NYSE:VTR) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

VEN:Germany V1TA34:Brazil

Address

353 North Clark Street, Suite 3300, Chicago, IL, USA, 60654

Website

https://www.ventasreit.com

Ventas owns a diversified healthcare portfolio of nearly 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 3% of net operating income.

Executives

Walter C Rakowich	director	14100 E 35TH PL, AURORA CO 80011
Debra A Cafaro	director, officer: Chairman, President and CEO	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sumit Roy	director	600 LA TERRAZA BOULEVARD, ESCONDIDO CA 92025
Michael J Embler	director	C/O NMI HOLDINGS, INC., 2100 POWELL STREET, EMERYVILLE CA 94608
Robert D. Reed	director	47 DONALD DRIVE, ORINDA CA 94563
James D Shelton	director	3901 TURTLE CREEK BLVD. #12, DALLAS TX 75219
Richard I Gilchrist	director	5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Robert F Probst	officer: EVP, CFO and Acting CAO	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Gregory R Liebbe	officer: SVP, Chief Accounting Officer	500 N. HURSTBOURNE PARKWAY, SUITE 200, LOUISVILLE KY 40222
Maurice S Smith	director	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Marguerite M Nader	director	2S601 AVENUE LA TOURS, OAK BROOK IL 60523
Carey S. Roberts	officer: EVP and GC	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
James Justin Hutchens	officer: EVP Sr Housing North America	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
John D. Cobb	officer: SVP & Chief Investment Officer	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sean P. Nolan	director	C/O INTERMUNE, INC., 3280 BAYSHORE BLVD., BRISBANE CA 94005